EMA公开正上市许可的药品品种信息

2012-03-08 13:08  下载量:2

资料摘要

资料下载

This document lists information on applications for centralised marketing authorisation for human medicines that the European Medicines Agency has received for evaluation. It includes the international non-proprietary names (INN) and therapeutic areas for all new innovative medicines under evaluation by the Committee for Medicinal Products for Human Use (CHMP). For generic and biosimilar medicines, it includes the INN (active moiety only, with no information on salt, ester or derivative) and therapeutic area. This list only includes information for medicines whose applications have been validated. Information on designated orphan medicines that are being assessed for marketing authorisation is also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP). ......

资料下载

文献贡献者

相关资料 更多

相关产品

当前位置: 美国PhD科技有限公司 资料 EMA公开正上市许可的药品品种信息

关注

拨打电话

留言咨询